ADVERTISEMENT
Niall Dinwoodie is head of product characterization, biopharmaceutical services, at Charles River
Despite their difficult approval pathway, biobetters offer the potential for innovation and decreased healthcare costs.
A good understanding of European regulations governing batch release testing will facilitate your collaboration with a contract laboratory.